Browse studies, page 1085
Page 1085 of 1,203, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Treatment of Refractory Syndrome of Inappropriate Antidiuresis With Sodium-Glucose Cotransporter-2 Inhibitor AACE endocrinology and diabetes, 2026
- Berberine Poisoning with Polymorphic Ventricular Tachycardia: A Case Report Clinical practice and cases in emergency medicine, 2026
- Normal glycosylated hemoglobin masking glucose dysregulation in a patient with pancreatic and hematologic disease JCEM case reports, 2026
- ST-Segment Elevation Myocardial Infarction (STEMI) With a Fishy Twist: A Case of Kounis Syndrome Following Seafood Ingestion Cureus, 2026
- Euglycemic Diabetic Ketoacidosis under Empagliflozin during Neoadjuvant Pembrolizumab and Chemotherapy in Early Breast Cancer: A Case-Report Case reports in oncology, 2026
- Biventricular Heart Failure With Reduced Ejection Fraction in a Young Male: A Case Report Cureus, 2026
- Successful Control of Late-Onset Nephrotic Syndrome in FN1-Associated Fibronectin Glomerulopathy: A 17-Year Clinical Course Nephrology (Carlton, Vic.), 2026
- Post-Diphtheritic Myocarditis with Right Ventricular Thrombus: A Rare Cardiac Complication International medical case reports journal, 2026
- Undifferentiated Purpuric and Desquamative Drug Eruption After Pembrolizumab and Empagliflozin Exposure: A Clinicopathologic Diagnostic Pitfall Cureus, 2026
- SGLT-2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis Masked by Concurrent Pneumoperitoneum Following Spinal Surgery Under General Anesthesia: A Case Report Journal of clinical medicine, 2026
- Sodium-Glucose Linked Transporter-2 (SGLT-2) Inhibitor-Associated Unmasking of Myasthenia Gravis in a Patient With Undiagnosed Thymic Follicular Hyperplasia: The First Reported Case Cureus, 2026
- Renal Pelvis Epidermoid Cyst Mimicking Staghorn Calculus: Successful Treatment with Percutaneous Approach (PCN) Urology journal, 2026
- Acute esophageal necrosis complicating diabetic ketoacidosis in a patient with type II diabetes mellitus and excessive cola consumption: a case report Diabetology international, 2022
- A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery AACE clinical case reports, 2021
- Euglycemic diabetic ketoacidosis caused by empagliflozin complicated by failure to thrive in a geriatric patient Archive of clinical cases, 2023
- Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus Cureus, 2023
- Beneficial effects of empagliflozin on hematocrit levels in a patient with severe anemia Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2021
- Resolution of severe gastroparesis induced by parasympathetic surge following facial trauma: a case report Journal of medical case reports, 2024
- Euglycemic Diabetic Ketoacidosis in a Lung Cancer Patient Using Empagliflozin Case reports in critical care, 2020
- Long-term Empagliflozin Use in Chronic Syndrome of Inappropriate Antidiuresis Due to Traumatic Subarachnoid Hemorrhage JCEM case reports, 2026
- Fournier's gangrene and diabetic ketoacidosis with lower-than-anticipated glucose levels associated with SGLT-2 inhibitor: A double trouble Medical journal, Armed Forces India, 2023
- Anti-Proteinuric Effect of GLP1-RA as Add-On to SGLT2-i and ACE-i in a Diabetic Patient with IgA Nephropathy Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2024
- Ketoacidosis Due to Empagliflozin, a Paradigm Shift: Case Report and Review of Literature Current diabetes reviews, 2019
- Beyond Glucose Levels: Redefining Diabetic Ketoacidosis-A Case of Hypoglycemic Diabetic Ketoacidosis AACE clinical case reports, 2025
- Euglycemic Diabetic Ketoacidosis Associated with Empagliflozin Use in the Course of the SARS-Cov-2 Pandemic Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2020
- Fournier's gangrene in a man on empagliflozin for treatment of Type 2 diabetes Diabetic medicine : a journal of the British Diabetic Association, 2017
- A Rare but Life-Threatening Case of Fournier's Gangrene Caused by Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor, Empagliflozin Cureus, 2022
- A Case of Severe Metabolic Acidosis due to Jardiance-Induced Euglycemic Diabetic Ketoacidosis Cureus, 2021
- Emphysematous Cystitis and Urinary Retention in a Male Patient With Diabetes Mellitus Type 2 Treated With Empagliflozin AACE clinical case reports, 2022
- Euglycemic Diabetic Ketoacidosis Induced by Sodium-Glucose Cotransporter-2 Inhibitor Use and Coronary Angiography: A Case Report Cureus, 2024
- Untargeted metabolomic profiling in a patient with glycogen storage disease Ib receiving empagliflozin treatment JIMD reports, 2022
- SGLT2 Inhibitors for Treatment of Refractory Hypomagnesemia: A Case Report of 3 Patients Kidney medicine, 2020
- Bilateral gangrene of fingers in a patient on empagliflozin: First case report World journal of diabetes, 2019
- Hemochromatosis Gene Mutation in Persons Developing Erythrocytosis on Combined Testosterone and SGLT-2 Inhibitor Therapy Journal of investigative medicine high impact case reports, 2022
- Sodium-Glucose Cotransporter 2 Inhibitors and Management of Refractory Hypomagnesemia Without Overt Urinary Magnesium Wasting: A Report of 2 Cases Kidney medicine, 2022
- Immune checkpoint inhibitor-induced takotsubo syndrome and diabetic ketoacidosis: rare reactions BMJ case reports, 2021
- Repurposing of Empagliflozin as a Possible Treatment for Neutropenia and Inflammatory Bowel Disease in Glycogen Storage Disease Type Ib: A Case Report Cureus, 2022
- Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor Blood, 2020
- Left ventricular noncompaction with intractable heart failure responsive to empagliflozin Journal of cardiology cases, 2018
- Empagliflozin-Induced Nondiabetic Ketoacidosis in Advanced Alcoholic Liver Disease ACG case reports journal, 2025
- Effect of Sodium-Glucose Co-Transporter-2 Inhibitor on Estimated Plasma Volume in a Patient With Heart Failure With Reduced Ejection Fraction and a Patient With Heart Failure With Preserved Ejection Fraction Clinical cardiology, 2024
- Rapid Onset of Diabetic Ketoacidosis After SGLT2 Inhibition in a Patient With Unrecognized Acromegaly The Journal of clinical endocrinology and metabolism, 2017
- Fulminant Emphysematous Pyelonephritis by Candida glabrata in a Kidney Allograft Nephron, 2020
- Empagliflozin in kidney transplant recipients with chronic kidney disease G3a-4 and metabolic syndrome: Five Japanese cases BMC nephrology, 2022
- Euglycaemic ketoacidosis: a potential new hazard to plastic surgery day case and inpatient procedures BMJ case reports, 2017
- Managing spondylitis tuberculosis in a patient with underlying diabetes and hypothyroidism: A case report World journal of clinical cases, 2022
- Chronic Kidney Disease Stage G4 in a Diabetic Patient Improved by Multi-Disciplinary Treatments Based Upon Literature Search for Therapeutic Evidence Cardiology research, 2022
- Sodium-glucose cotransporter type 2 channel inhibitor: Breakthrough in the treatment of neutropenia in patients with glycogen storage disease type 1b? JIMD reports, 2022
- Euglycaemic diabetic ketoacidosis in a patient with pancreatitis and type 2 diabetes on empagliflozin BMJ case reports, 2022
- Case Report of Empagliflozin-Induced Cutaneous Polyarteritis Nodosa Journal of cutaneous medicine and surgery, 2018
- Empagliflozin-Associated Pancreatitis: A Consideration for SGLT2 Inhibitors ACG case reports journal, 2021
- Angioedema Shortly After Adding Empagliflozin to Losartan Cureus, 2025
- Sodium-Glucose Cotransporter 2 Inhibitors Improve Chronic Diabetic Macular Edema Case reports in ophthalmological medicine, 2020
- Extraventricular Neurocytoma of the Sellar Region Presenting With Syndrome of Inappropriate Antidiuresis JCEM case reports, 2024
- Self-Induced Euglycemic Diabetic Ketoacidosis: When to Stop the Drip Cureus, 2022
- Postop Complication With Euglycemic Diabetic Ketoacidosis in a Patient Receiving Empagliflozin Cureus, 2022
- Hypoglycemia in a patient treated with a SGLT2-inhibitor with HFrEF without diabetes mellitus Deutsche medizinische Wochenschrift (1946), 2022
- From glucosuria to dialysis: a case report of osmotic nephropathy due to an SGLT2 inhibitor BMC nephrology, 2026
- A Case of Euglycemic Diabetic Ketoacidosis: SGLT2 Inhibitor Complication Triggering Acute Coronary Syndrome and Cardiac Arrest Post Coronary Artery Bypass Grafting (CABG) Cureus, 2025
- Capivasertib-Induced Diabetes Successfully Managed With Insulin-Independent Glucose-Lowering Agents: A Case Report Cureus, 2026
- SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: A Case Report Kidney medicine, 2020
- Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis Masked by Urinary Tract Infection Cureus, 2024
- Masked Primary Hyperparathyroidism by Empagliflozin Use Cureus, 2022
- Case of sodium-glucose cotransporter-2 inhibitor-associated euglycaemic diabetic ketoacidosis BMJ case reports, 2021
- Euglycaemic diabetic ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors Internal medicine journal, 2017
- Empagliflozin-associated postoperative mixed metabolic acidosis. Case report and review of pathogenesis BMC endocrine disorders, 2023
- An Unsuspected Case of Euglycemic Diabetic Ketoacidosis With Twists Cureus, 2022
- Successful Management of HFpEF-Related Pulmonary Hypertension With Systemic-Level Pressures Using Sacubitril-Valsartan and Empagliflozin JACC. Case reports, 2025
- Empagliflozin-Associated Pancreatitis in the Setting of Hyperglycemic Hyperosmolar Syndrome Cureus, 2024
- SGLT2i Improves Glycemic Control in Patients With Congenital Severe Insulin Resistance Pediatrics, 2022
- Clinical Remission of Severe Crohn's Disease with Empagliflozin Monotherapy in a Pediatric Patient with Glycogen Storage Disease Type 1b JPGN reports, 2023
- A Rare Case of Sodium-Glucose Cotransporter-2 Inhibitor-Induced Acute Pancreatitis Cureus, 2023
- Misleading Presentation: Chest Pain Masking Euglycemic Diabetic Ketoacidosis Possibly Induced by Empagliflozin Cureus, 2023
- Fournier's Gangrene in an HIV-Positive Patient on Empagliflozin for the Treatment of Diabetes Mellitus Cureus, 2022
- Case Report: Diabetic ketoacidosis after co-administration of empagliflozin and probenecid Wellcome open research, 2023
- Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor Case reports in endocrinology, 2022
- Empagliflozin induced euglycemic diabetic ketoacidosis. A case reports Annals of medicine and surgery (2012), 2022
- Empagliflozin-Induced Pancreatitis: A Case Report Pattern Cureus, 2022
- Euglycemic Diabetic Ketoacidosis, Recurrent Genital Abscess, and Proximal Renal Tubular Acidosis With Concurrent SGLT-2 Inhibitor: More Than an Association Cureus, 2024
- SLGT2 Inhibitor Rescues Myelopoiesis in G6PC3 Deficiency Journal of clinical immunology, 2022
- Late Diagnosis of Prader-Willi Syndrome in an Adolescent With Significant Complications of Type 2 Diabetes JCEM case reports, 2025
- Dapagliflozin in the treatment of heart failure with preserved ejection fraction Vnitrni lekarstvi, 2023
- Adverse Side Effects: Empagliflozin-Related Acute Pancreatitis Case Report Cureus, 2020
- Empagliflozin May be a Game Changer in Managing Pulmonary Embolism: A Case Report Mymensingh medical journal : MMJ, 2024
- Improvement in Serum Magnesium Levels With Sodium-Glucose Cotransporter 2 Inhibitors JCEM case reports, 2023
- Acute Pancreatitis With Normal Amylase and Lipase: A Diagnostic Dilemma Cureus, 2024
- Sodium-glucose cotransporter 2 inhibitor-associated severe epididymo-orchitis BMJ case reports, 2022
- Euglycemic diabetic ketoacidosis in the setting of acute intracerebral hemorrhage Surgical neurology international, 2024
- Risk of Euglycemic Diabetic Ketoacidosis Can Persist After Discontinuation of Sodium-glucose Cotransporter-2 Inhibitors JCEM case reports, 2025
- Empagliflozin-related DRESS syndrome European heart journal. Case reports, 2025
- Empagliflozin-induced Myopathy JCEM case reports, 2024
- A rare case of incidental asymptomatic emphysematous cystitis in a patient taking empagliflozin Urology Case Reports, 2026
- 8084 Euglycemic Diabetic Ketoacidosis in Vulnerable Populations: A Case Series Journal of the Endocrine Society, 2024
- The Significance of Precise Diabetes Diagnosis: A Case of Euglycemic Diabetic Ketoacidosis Induced by the Introduction of Empagliflozin with Simultaneous Reduction of Insulin Dosage European Journal of Case Reports in Internal Medicine, 2024
- SGLT2-Inhibitor induced euglycemic ketoacidosis in acute surgical patients 2017
- Composite endpoints in health technology assessment: Part 2 – expanding the evidence base with a framework for best modeling practice Journal of Comparative Effectiveness Research, 2025
- Dapagliflozin ameliorates Lafora disease phenotype in a zebrafish model Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2025
- Complications Secondary to the Use Of Sglt2 Inhibitors in Oncological Patients: A Series of 5 Cases European Journal of Case Reports in Internal Medicine, 2023
- Empagliflozin-induced Diabetic Ketoacidosis Unmasking a Type 1 Diabetes Diagnosis Clinical Practice and Cases in Emergency Medicine, 2019
- Empagliflozin ameliorated neutropenia in a girl with glycogen storage disease Ib Pediatrics International, 2021
